SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-102053
Filing Date
2024-09-23
Accepted
2024-09-23 16:21:47
Documents
14
Period of Report
2024-09-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2424316d1_8k.htm   iXBRL 8-K 37000
2 EXHIBIT 10.1 tm2424316d1_ex10-1.htm EX-10.1 1193684
  Complete submission text file 0001104659-24-102053.txt   1625029

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ogn-20240917.xsd EX-101.SCH 3009
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogn-20240917_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogn-20240917_pre.xml EX-101.PRE 22356
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2424316d1_8k_htm.xml XML 3672
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

IRS No.: 464838035 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40235 | Film No.: 241316477
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)